Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Abtard
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abtard 40mg modified-release tablets
0407020ADBMAEAH
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 125 |
|
Abtard 30mg modified-release tablets
0407020ADBMAFAR
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 73 |
|
Abtard 60mg modified-release tablets
0407020ADBMAGAQ
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 64 |
|
Abtard 10mg modified-release tablets
0407020ADBMABAF
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 47 |
|
Abtard 80mg modified-release tablets
0407020ADBMAHAI
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 31 |
|
Abtard 15mg modified-release tablets
0407020ADBMACAS
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 23 |
|
Abtard 5mg modified-release tablets
0407020ADBMAAAK
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 7 |
|
Abtard 20mg modified-release tablets
0407020ADBMADAG
|
Abtard | Oxycodone hydrochloride | Central Nervous System | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.